The PI3K/Akt pathway: a target for curcumin's therapeutic effects

被引:0
|
作者
Aliyari, Mahdieh [1 ]
Ghoflchi, Sahar [1 ]
Hashemy, Seyed Isaac [1 ]
Hashemi, Seyedeh Fatemeh [2 ]
Reihani, Amirali [2 ]
Hosseini, Hossein [1 ,3 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Clin Biochem, Mashhad, Iran
[2] Mashhad Univ Med Sci, Student Res Comm, Fac Med, Mashhad, Iran
[3] Mashhad Univ Med Sci, Metab Syndrome Res Ctr, Mashhad, Iran
关键词
Curcuma longa; Phosphoinositide; 3-kinase; Protein kinase B; Curcumin; Metabolic disease; Neurodegenerative disease; Kidney disorder; EPITHELIAL-MESENCHYMAL TRANSITION; FATTY LIVER-DISEASE; SIGNALING PATHWAY; ANTIINFLAMMATORY PROPERTIES; OXIDATIVE STRESS; NATURAL-PRODUCTS; PROTEIN-KINASE; HIGH GLUCOSE; INHIBITION; INJURY;
D O I
10.1007/s40200-025-01563-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe purpose of this review study is to investigate the effect of curcumin on the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway in various diseases. Curcumin, the main compound found in turmeric, has attracted a lot of attention for its diverse pharmacological properties. These properties have increased the therapeutic potential of curcumin in chronic diseases such as cardiovascular disease, Type 2 diabetes, obesity, non-alcoholic fatty liver disease, kidney disease, and neurodegenerative diseases. One of the main mechanisms of the effect of curcumin on health is its ability to modulate the PI3K/Akt signaling pathway. This pathway plays an important role in regulating vital cellular processes such as growth, cell survival, metabolism, and apoptosis. Disruption of the PI3K/Akt signaling pathway is associated with the incidence of several diseases.MethodsElectronic databases including PubMed, Google Scholar, and Scopus were searched with the keywords "phosphoinositide 3-kinase" AND "protein kinase B "AND "curcumin" in the title/abstract. Also, following keywords "non-alcoholic fatty liver disease" AND "diabetes" AND "obesity" AND "kidney disease" and "neurodegenerative diseases" was searched in the whole text.ResultsResearch indicates that curcumin offers potential benefits for several health conditions. Studies have shown it can help regulate blood sugar, reduce inflammation, and protect the heart, kidneys, and brain.ConclusionThis protective effect is partially achieved by regulating the PI3K-Akt survival pathway, which helps improve metabolic disorders and oxidative stress. By examining how curcumin affects this vital cell pathway, researchers can discover new treatment strategies for a range of diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] PI3K/AKT PATHWAY IS INVOLVED IN MDS PATHOGENESIS AND MAY CONSTITUTE A POTENTIAL THERAPEUTIC TARGET
    Rezende, D. C.
    Pacheco, L. Z.
    Pelloso, L. A. F.
    Chauffaille, M. L. L. F.
    Yamamoto, Y.
    Silva, M.
    Kerbauy, D. B.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S82 - S82
  • [22] PI3K/AKT pathway: A potential therapeutic target in cerebral ischemia-reperfusion injury
    Han, Yiming
    Sun, Yu
    Peng, Shiyu
    Tang, Tingting
    Zhang, Beibei
    Yu, Ruonan
    Sun, Xiaoyan
    Guo, Shanshan
    Ma, Lijuan
    Li, Peng
    Yang, Pengfei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998
  • [23] The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease
    Goyal, Ahsas
    Agrawal, Anant
    Verma, Aanchal
    Dubey, Nandini
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2022, 129
  • [24] The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
    Carnero, Amancio
    Blanco-Aparicio, Carmen
    Renner, Oliver
    Link, Wolfgang
    Leal, Juan F. M.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (03) : 187 - 198
  • [25] PI3K/Akt/mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
    Narayanankutty, Arunaksharan
    CURRENT DRUG TARGETS, 2019, 20 (12) : 1217 - 1226
  • [26] The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway
    Hamzehzadeh, Leila
    Atkin, Stephen L.
    Majeed, Muhammed
    Butler, Alexandra E.
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (10) : 6530 - 6537
  • [27] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [28] PI3K PATHWAY PROVIDES A NOVEL THERAPEUTIC TARGET FOR PAEDIATRIC EPENDYMOMA
    Rogers, Hazel
    Chapman, Rebecca
    Mayne, Cerys
    Duane, Holly
    Kilday, John-Paul
    Coyle, Beth
    Grundy, Richard
    NEURO-ONCOLOGY, 2014, 16 : 21 - 21
  • [29] PI3K/Akt Pathway Mutations in Retinoblastoma
    Cohen, Yoram
    Merhavi-Shoham, Efrat
    Avraham-Lubin, Bat Chen R.
    Savetsky, Michael
    Frenkel, Shahar
    Pe'er, Jacob
    Goldenberg-Cohen, Nitza
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (11) : 5054 - 5056
  • [30] PTEN/PI3K PATHWAY AS A THERAPEUTIC TARGET FOR ALLERGIC AIRWAYS INFLAMMATION
    Park, S. J.
    Lee, Y. C.
    DRUGS OF THE FUTURE, 2009, 34 (08) : 673 - 680